- Home
- XPOF vs VNDA Comparison
XPOF vs VNDA Comparison
Compare XPOF & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPOF
- VNDA
- Stock Information
- Founded
- XPOF 2017
- VNDA 2002
- Country
- XPOF United States
- VNDA United States
- Employees
- XPOF N/A
- VNDA N/A
- Industry
- XPOF Services-Misc. Amusement & Recreation
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- XPOF Consumer Discretionary
- VNDA Health Care
- Exchange
- XPOF Nasdaq
- VNDA Nasdaq
- Market Cap
- XPOF 295.1M
- VNDA 261.7M
- IPO Year
- XPOF 2021
- VNDA 2006
- Fundamental
- Price
- XPOF $10.04
- VNDA $4.78
- Analyst Decision
- XPOF Buy
- VNDA Strong Buy
- Analyst Count
- XPOF 9
- VNDA 3
- Target Price
- XPOF $13.94
- VNDA $15.33
- AVG Volume (30 Days)
- XPOF 788.3K
- VNDA 408.4K
- Earning Date
- XPOF 07-31-2025
- VNDA 07-30-2025
- Dividend Yield
- XPOF N/A
- VNDA N/A
- EPS Growth
- XPOF N/A
- VNDA N/A
- EPS
- XPOF N/A
- VNDA N/A
- Revenue
- XPOF $317,536,000.00
- VNDA $201,351,000.00
- Revenue This Year
- XPOF $1.62
- VNDA $16.86
- Revenue Next Year
- XPOF $6.11
- VNDA $39.78
- P/E Ratio
- XPOF N/A
- VNDA N/A
- Revenue Growth
- XPOF N/A
- VNDA 13.37
- 52 Week Low
- XPOF $6.64
- VNDA $3.81
- 52 Week High
- XPOF $18.95
- VNDA $6.37
- Technical
- Relative Strength Index (RSI)
- XPOF 63.94
- VNDA 53.88
- Support Level
- XPOF $8.86
- VNDA $4.85
- Resistance Level
- XPOF $10.14
- VNDA $5.12
- Average True Range (ATR)
- XPOF 0.53
- VNDA 0.18
- MACD
- XPOF 0.28
- VNDA 0.01
- Stochastic Oscillator
- XPOF 93.97
- VNDA 54.05
About XPOF Xponential Fitness Inc.
Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.